ESG Report

Overview

The report describes PMV Pharma's ESG governance through an ESG Working Group overseen by a board committee. It reports zero health and safety-related incidents in 2023. The company highlights a 6% voluntary turnover rate, with 56% of employees identifying as female and 51% as ethnically diverse. It also describes responsible clinical-trial practices, vendor quality oversight, and privacy and cybersecurity controls.

Document

Report type: Sustainability Report
Class: Dedicated
Scope: Full report
Fiscal year: 2024
Language: English
Pages
File size

Reporting standards, commitments and assurance details are available with a free account.

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP
Other

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services